Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP478842.RAY0Q9nw077oBPNafNFTVGpusz3dZcP9BMGbslMzarYCM130_assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478842.RAY0Q9nw077oBPNafNFTVGpusz3dZcP9BMGbslMzarYCM130_provenance.
• assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP557968.RAWcBFp4ZJPp-abObG1UmzB-nMX5ECpqwmMixN0GdYZFc130_assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557968.RAWcBFp4ZJPp-abObG1UmzB-nMX5ECpqwmMixN0GdYZFc130_provenance.
• NP685441.RA7QVdvtPaG-K55b3v-jyE0jHev7nt0RmlfHacNtsQFaE130_assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685441.RA7QVdvtPaG-K55b3v-jyE0jHev7nt0RmlfHacNtsQFaE130_provenance.
• assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1012058.RAUC1YiJ9af0lOhPTiAxzWphE-nnpgUMknTSsO7H40BoM130_assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012058.RAUC1YiJ9af0lOhPTiAxzWphE-nnpgUMknTSsO7H40BoM130_provenance.
• NP616396.RAkrl3HQgbus7Q3EZoOTcsoI-OIJpXfkUPfbdIUWFg8Ac130_assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616396.RAkrl3HQgbus7Q3EZoOTcsoI-OIJpXfkUPfbdIUWFg8Ac130_provenance.
• NP1012056.RAoE5Jr8YFMHNEeBAhkEg_PiodRi4NB_zFKc-HO5PWqW8130_assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012056.RAoE5Jr8YFMHNEeBAhkEg_PiodRi4NB_zFKc-HO5PWqW8130_provenance.
• NP1012057.RAtDcXsdUeWVKW3pY3DTSYIeaiigJsBbL9ByWzAJrd-t8130_assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012057.RAtDcXsdUeWVKW3pY3DTSYIeaiigJsBbL9ByWzAJrd-t8130_provenance.
• NP246699.RA1iVQKF7v13PX1mXM_F4C9LfKDC4MLiOhiMTyy8HAFpw130_assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246699.RA1iVQKF7v13PX1mXM_F4C9LfKDC4MLiOhiMTyy8HAFpw130_provenance.
• NP246717.RA5t1zVyI_BWuIbtaz30wmoiXqSGEQfkmMO-7W1J_Iu1c130_assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246717.RA5t1zVyI_BWuIbtaz30wmoiXqSGEQfkmMO-7W1J_Iu1c130_provenance.
• NP616388.RAIGXahlbuE4SALZlbTqAx1lE8qfBXJGbHTMesXobBNsE130_assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616388.RAIGXahlbuE4SALZlbTqAx1lE8qfBXJGbHTMesXobBNsE130_provenance.
• NP1012055.RAOY4Ox7w9HMw7yl8iqD-GayG8_7Zh7ulz0nFsx2DtaXY130_assertion description "[A different approach is suggested by the concurrence of autoantibodies and their antigenic targets in the absence of clinical disease, such as platelet factor 4 in heparin-induced thrombocytopenia and ?(2)-glycoprotein-I (?(2)GPI) in antiphospholipid syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012055.RAOY4Ox7w9HMw7yl8iqD-GayG8_7Zh7ulz0nFsx2DtaXY130_provenance.